Clinical Guidance Remains Non-Specific For Drugs To Reduce Bone Cancer Damage

Bone cancer-related fractures and pain can be reduced by drug treatment, but no one drug is superior, according to a review published in The Cochrane Library. Researchers undertook a systematic review of the current evidence on bisphosphonate drugs, which are used to prevent bone damage in multiple myeloma...

Source: http://www.medicalnewstoday.com/releases/245436.php

SEAGATE TECHNOLOGY EASTMAN KODAK CO APPLIED MATERIALS, INC. SAIC, INC.